Brand semaglutide
Sold by Immortals · every brand semaglutide record
The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.
What you actually pay
Per month
$1,550
| Medication · Wegovy (Tablets or Injections) | $1,550 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Wegovy (Tablets or Injections) “Wegovy® (semaglutide) From $1,550/mo* Activates GLP-1 receptors, the gut hormone that signals appetite and satiety, supporting long-term weight loss.” source, read September 2, 2026 | Per month$1,550 | Charged today$1,550 |
We earn nothing from this link. Immortals has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
One reading so far. A price history appears here after the next verification pass.
- September 2, 2026 — Entry added to the register
Sourcing and terms
| Cancellation | “Cancellation. You can cancel your subscription at any time through the settings in your account. When you cancel a paid subscription, you cancel only future charges associated with your subscription, but the cancellation will become effective at the end of your current subscription period.” |
|---|---|
| Membership | None. “Immortals Medicine has no membership fees or insurance requirements.” |
Not yet checked: pharmacy, states, prescriber and consult fee.
Recorded from immortals.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2, 2026 — Immortals (Bryan Johnson's platform) states '$0 Membership fees' directly on the semaglutide product page, so the per-drug prices are recorded as prices, not membership. All four price footnotes say 'Billed quarterly with a three-month commitment paid up front,' so term is recorded as 3 (a quarterly commitment) with perMonth as shown and upfront left null since the actual quarterly total charge isn't separately stated. Zepbound® is explicitly branded 'KwikPen®' in its own product name, so form=injection-pen is recorded for that entry; Wegovy's page toggles between 'Tablets' and 'Injections' at one static price with no per-form breakdown, so form is not-disclosed there. No states or prescriber sync/async statement could be found on the pages checked.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.